TIMARA STELLING: Open Payments
NPI 1235595240 · PURCELL, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,978 in 105 payments from 16 companies in 2025. Trend: 2023 $1,573 · 2024 $1,848 · 2025 $1,978
Food & beverage: $1,978
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $463 |
| PFIZER INC. | 23 | $383 |
| AstraZeneca Pharmaceuticals LP | 13 | $283 |
| Lilly USA, LLC | 11 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $98 |
| Amgen Inc. | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| ABBVIE INC. | 3 | $51 |
Products named: Rybelsus, ELIQUIS, Ozempic, FARXIGA, MOUNJARO, CAPLYTA, JARDIANCE, NURTEC ODT.
Industry payments across OK — which companies pay providers there.
